Covalon Technologies Ltd. (TSXV:COV)

Market Cap	61.96M
Revenue (ttm)	34.67M
Net Income (ttm)	4.73M
Shares Out	27.42M
EPS (ttm)	0.18
PE Ratio	12.66
Forward PE	26.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,400
Average Volume	22,081
Open	2.240
Previous Close	2.270
Day's Range	2.240 - 2.260
52-Week Range	0.970 - 4.300
Beta	0.45
RSI	43.34
Earnings Date	May 28, 2025

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by second...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 37
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: COV